Kaleido Biosciences

KLDO

OTCHealth Care

Income Statement

Total Revenue$1.97M

Gross Profit$1.97M

Operating Income$-78.8M

EBITDA$-75.81M

EBIT$-78.23M

Pre-tax Income$-90.29M

Net Income$-81.09M

Cash Equivalent$40.64M

Total Debt$21.69M

Book Value$10.61M

Book Value Per Share0.25

Return on Equity (ROE)-851.21%

Return on Assets (ROA)-180.08%

Return on Invested Capital (ROI)-279.52%

Net Profit Margin-8178.26%

Current Ratio1.43

Quick Ratio1.30

Long-Term Debt / Equity0.52